Veristat Acquires Biometrics-focused Instat Clinical Research

Contributed by: Business Wire

Logo

Tags

Health Technology

Stem Cells

Consulting

Pharmaceutical

Oncology

Professional Services

Biometrics

Medical Devices

Infectious Diseases

Genetics

Clinical Trials

Biotechnology

Science

Data Analytics

Research

Health

Instat

More Like This

Veristat Joins the Alliance for Regenerative Medicine (ARM) to Help Address Critical Issues Impacting the Advanced Therapy Sector

Rachel Page, Chief Commercial Officer, Veristat (Photo: Business Wire)

Veristat Appoints New Chief Commercial Officer

PR Newswire associated0

Bright Data and Statista partner to deliver new data sets and insights for intelligent, fact-based decisions

Gabriela Rosu, MD Senior Director, Global Medical Affairs Veristat (Photo: Business Wire)

Veristat Appoints Gabriela Rosu, M.D., to Lead Growing Medical Affairs Team

Medidata and Bioforum Bolster Decade-Long Relationship to Advance Clinical Data and Biometric Solutions for Clinical Trials

Bureau Veritas Acquires Security Innovation Inc. to Reinforce Its Cybersecurity Expertise in the Software Domain

ClinChoice Extends 13-Year Medidata Partnership with the Addition of Clinical Data Studio to Improve Data Management and Strengthen Clinical Trial Capabilities

Scientist.com Adds Trial Insights™ to Clinical Labs Navigator™ Solution, Giving Researchers Instant Access to Global Clinical-Trial Intelligence